Dutasteride
Product Images NDC 51013-190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 51013-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

90ct.jpg (90ct)

90ct.jpg (90ct)
Each capsule contains 0.5 mg of Dutasteride. It is recommended to store at 25°C (77°F) and excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The usual adult dosage is 0.5 mg once daily. These capsules should be kept out of reach of children and women who are or may potentially be pregnant. Further dosing information is available on the prescribing information. If the bottle seal is broken, do not accept the medication and contact the manufacturer immediately. This information is intended only for prescription use with 90 capsules provided by PuraCap Pharmaceutical LLC, distributed by Humanwell PuraCap Pharmaceutical in Wuhan, Hubel 430206, China.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This table shows the cumulative number of events and patients at risk over a period of 24 months of treatment. The data is categorized into two groups- Placebo and Dutasteride. It is not available what the treatment was for or what the events represent.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
Not available.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
This appears to be a chart displaying the mean change from baseline (in mL/sec) over 24 months of treatment for two groups: one that received a placebo (with sample sizes ranging from 2101 to 2105) and another that received dutasteride (with sample sizes ranging from 2103 to 2104). The x-axis shows the months of treatment.*
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.